• Flanders Investment & Trade
  • Team Vesalius

Catherine Verfaillie was born in Ieper in 1957. She obtained an MD from the Katholieke Universiteit Leuven (KU Leuven) in 1982. After graduation, she trained in internal medicine and the treatment of malignant blood diseases such as leukemia. Verfaillie is best known for her work in the field of stem cell research.

Catherine Verfaillie

KU Leuven

Head of the KU Leuven Stem Cell Institute

Leaving for Minnesota

In 1987, after her specialization in internal medicine, Verfaillie departed to the US to serve as a research fellow at the University of Minnesota. She worked in the lab of Phillip McGlave on topics including hematopoiesis and stromal control of hematopoietic stem cells, and subsequently on stem cells with greater differentiation potential, such as pluripotent stem cells. She became assistant professor in the University of Minnesota’s Department of Medicine in 1991, and in 1998 became a full professor. In 1999, she started up and headed the Stem Cell Institute at the University of Minnesota.

Where she is today

She returned to Belgium in 2005 to become head of the KU Leuven Stem Cell Institute. Verfaillie has built up an extensive international research network in the stem cell  field. She is the president of the Belgian Society of Stem Cell Research, and was president of the Society of Experimental Hematology. She serves as reviewer for numerous national and international granting agencies, as a member  academic and industrial scientific advisory boards, and on the editorial boards of numerous scientific journals.

Her trophy case

In 2003, Verfaillie received an honorary doctorate from KU Leuven for her fundamental contributions to stem cell research. She was awarded the José Carreras Award that same year and is the recipient of the Leukemia Society of America Award and the Damashek Prize from the American Society of Hematology.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?